A new modeling study suggests that gastric-cancer screening could be cost-effective in high-risk racial and ethnic groups in the U.S. When diagnosed at an early stage, patients with gastric adenocarcinoma (GA) have a five-year survival rate of 95% to 99%. But, if detected later, the survival rate drops to less than 30%.
Thus, it is recommended for people to get screened early on. However, since the prevalence of noncardia intestinal-type gastric adenocarcinoma (NCGA) in the US is low, it is not recommended for everyone.
Results of the study showed that screening with upper endoscopy (EGD) and additional surveillance only if the test detected intestinal metaplasia (IM) or more severe pathology was cost effective for Asians Hispanics, and non-Hispanic blacks. For non-Hispanic whites, it was not cost effective.
Symptoms, Screening, & Early Detection
View Full Article
Related Videos